Healthcare Services

Low-Density Lipoprotein Test Market Expansion Outlook Through 2030 With Revenue Growth Insights

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Low-Density Lipoprotein Test Market By 2030?

The low-density lipoprotein test market size has experienced strong growth over recent years. It is projected to increase from $8.83 billion in 2025 to $9.32 billion in 2026, at a compound annual growth rate (CAGR) of 5.5%. The expansion observed in the past can be attributed to factors such as the increasing prevalence of cardiovascular diseases, early clinical reliance on LDL-C testing, a rising incidence of obesity and diabetes, the expansion of hospital-based diagnostic laboratories, and growing awareness of cholesterol management.

The low-density lipoprotein test market size is anticipated to experience robust expansion over the coming years, with projections indicating it will reach $11.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This projected growth during the forecast period is fueled by several factors, including an escalating focus on preventive healthcare, increased screening for dyslipidaemia, the broader implementation of advanced lipid testing methodologies, a heightened need for early detection of stroke and heart disease risks, and augmented healthcare expenditure on diagnostic services. Furthermore, key developments anticipated within this timeframe involve a greater emphasis on preventive cardiovascular screening, the expanding application of comprehensive lipid panel testing, an increasing requirement for regular cholesterol monitoring, the extended utilization of ldl testing in the context of metabolic disorders, and the rising uptake of point-of-care lipid testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9395&type=smp

What Major Growth Factors Are Impacting The Low-Density Lipoprotein Test Market?

An increasing occurrence of cardiovascular diseases is anticipated to drive the expansion of the low-density lipoprotein test market. These diseases encompass various conditions impacting the heart and blood vessels. The low-density lipoprotein test aids in addressing cardiovascular diseases by directly quantifying low-density lipoprotein levels in the heart. For example, in February 2024, data from the UK Parliament, a UK-based governing body, revealed that heart and circulatory diseases contribute to approximately 25% of all deaths in England, leading to over 140,000 fatalities annually and around 480 deaths daily, or one death every three minutes. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the low-density lipoprotein test market.

Which Segment Divisions Form The Structure Of The Low-Density Lipoprotein Test Market?

The low-density lipoprotein test market covered in this report is segmented –

1) By Product Type: Low-Density Lipoprotein Cholesterol (LDL-C), Low-Density Lipoprotein Particle Number (LDL-P), Low-Density Lipoprotein Particle Size (LDL-B), Other Product Types

2) By Component: Kits, Reagents, Devices, Other Components

3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types

4) By Distribution Channel: Direct Tenders, Retail

5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users

Subsegments:

1) By Low-Density Lipoprotein Cholesterol (LDL-C): Direct Measurement Tests, Calculated LDL-C Tests

2) By Low-Density Lipoprotein Particle Number (LDL-P): NMR (Nuclear Magnetic Resonance) Tests, Other Particle Counting Methods

3) By Low-Density Lipoprotein Particle Size (LDL-B): Gradient Gel Electrophoresis, Other Size Measurement Techniques

4) By Other Product Types: Lipid Panel Tests: Genetic Testing For Dyslipidemia, Point-Of-Care Testing Devices

What Trends Are Driving Changes In The Low-Density Lipoprotein Test Market?

Leading companies in the low-density lipoprotein (LDL) test market are concentrating on launching creative diagnostic solutions, such as advanced lipoprotein analysis systems, to enhance cardiovascular risk assessment, improve diagnostic precision, and optimize patient management. These advanced lipoprotein analysis systems leverage technologies like nuclear magnetic resonance (NMR) spectroscopy and algorithm-driven analysis to deliver more profound insights into lipid profiles, surpassing standard LDL-C measurements, and thereby refining clinical decision-making for individuals with cardiometabolic risks. For example, in July 2023, Numares Health, a health diagnostic firm based in Germany, released the AXINON LDL-p Test System. This FDA-cleared diagnostic instrument offers a more comprehensive evaluation of lipoproteins, providing insights into cardiac function beyond conventional LDL-C measurements. By employing nuclear magnetic resonance (NMR) spectroscopy, the system integrates sophisticated diagnostic algorithms to heighten its accuracy. It empowers physicians to better manage patients at increased risk for cardiovascular disease, particularly those with cardiometabolic risk factors.

Who Are The Prominent Players Across The Low-Density Lipoprotein Test Market?

Major companies operating in the low-density lipoprotein test market are Abbott Laboratories, Siemens Healthineers, F Hoffmann La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Bio Rad Laboratories Inc, DiaSorin SpA, Randox Laboratories Ltd, Sekisui Diagnostics, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc, OPKO Health Inc, Merck KGaA, Agilent Technologies Inc, Becton Dickinson and Company, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Eurofins Scientific SE, Home Access Health Corporation

Access The Complete Low-Density Lipoprotein Test Market Report:

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Which Geographic Region Represents The Largest Low-Density Lipoprotein Test Market Share?

North America was the largest region in the Low-Density Lipoprotein Test market in 2025. The regions covered in the low-density lipoprotein test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Low-Density Lipoprotein Test Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9395&type=smp

Browse Through More Reports Similar to the Global Low-Density Lipoprotein Test Market 2026, By The Business Research Company

Cholesterol Test Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Lipid Panel Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Poc Cholesterol Test Market 2026

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795